Cancer diagnostic and predictive biomarkers

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Buonaguro, Franco M ^a   Pauza, David ^b   Tornesello, Maria Lina ^a   Hainaut, Pierre ^c   Franco, Renato ^a   Marincola, Francesco M ^d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

^c INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^d SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER; PHARMACOLOGICAL BIOMARKER;

CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; EDITORIAL; PREDICTION; HUMAN; NEOPLASMS; PATHOLOGY; PROGNOSIS;

BIOMARKERS, PHARMACOLOGICAL; HUMANS; NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899531951     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/980163     Document Type: Editorial

References (3)

1. Srinivas P. R., Kramer B. S., Srivastava S., Trends in biomarker research for cancer detection. The Lancet Oncology 2001 2 11 698 704 2-s2.0-0035183179 10.1016/S1470-2045(01)00560-5 (Pubitemid 33085816)
2. Tornesello M. L., Buonaguro L., Tatangelo F., Botti G., Izzo F., Buonaguro F. M., Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 2013 102 2 74 83 10.1016/j.ygeno.2013.04.001
3. de Giorgi V., Buonaguro L., Worschech A., Tornesello M. L., Izzo F., Marincola F. M., Wang E., Buonaguro F. M., Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS ONE 2013 8 2 e56153 10.1371/journal.pone.0056153